⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMY News
Bristol-Myers Squibb Co.
NYSE Content Update: Two MSCI Indexes to Begin Trading on NYSE Arca Options
prnewswire.com
BMY
ICE
DT
Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity
prnewswire.com
HELP
TAK
BMY
PFE
CMPS
Therna Biosciences Appoints Biotech Veteran Devyn Smith, Ph.D., to Board of Directors and Expands Strategic and Scientific Advisory Leadership
prnewswire.com
PFE
BMY
ABBV
Microplastics Discovered in Prostate Tumors
prnewswire.com
PFE
AZN
BMY
XOM
Bristol Myers Squibb to Participate in the TD Cowen 46 th Annual Health Care Conference
businesswire.com
BMY
PorTal Access, Inc. Appoints Industry Veteran David Snow to Board of Directors to Advance Next-Generation Oncology Vascular Access Solutions
prnewswire.com
REGN
AZN
BMY
Chemotherapy Induced Peripheral Neuropathy (CIPN) Treatment Market Report 2026-2032: Revenues to Grow by $750M at 8.64% CAGR
globenewswire.com
ABBV
AMGN
PFE
BMY
MRK
REGN
SNY
TAK
NVS
GSK
HRTX
Bristol Myers Squibb Announces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in Adults with Alpha (α)-Thalassemia
businesswire.com
BMY
Bristol Myers Squibb Announces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in Adults with Alpha (α)-Thalassemia
businesswire.com
BMY
BioInvent Announces Nomination of Two New Board Members Ahead of 2026 Annual General Meeting
accessnewswire.com
AMRX
JNJ
PFE
BMY